All Reports

The US health expenditure is forecasted to reach US$6.07 trillion in 2027, experiencing growth at a CAGR of 5.61% during the period spanning from 2023 to 2027. The national health expenditure by source of funds can be segmented as follows: Managed care, Out of pocket, Investments and Others. In 2022, the dominant share was held by managed care segment. This was being followed by out of pocket, ..

The global RNAi therapeutics market is expected to record a value of US$1.26 billion in 2027, progressing at a CAGR of 10.02%, over the period 2023-2027. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and progress in collaborations and associate ..

The global hemophilia market is anticipated to reach US$16.78 billion in 2027, growing at a CAGR of 5.80% during the period spanning 2023-2027. The growth in the market has been driven by factors like increasing healthcare expenditure, surging identified hemophilia patient volume, increased focus on prophylactic treatment, rise in male population and favorable government initiatives. The market ..

European medical diagnostics market is expected to reach US$104.01 billion in 2027, growing at a CAGR of 4.52%, for the time period of 2023-2027. Factors such as rise in number of new cancer cases, expansion of medical device industry, growth in geriatric population, accelerating demand for In-Vitro Diagnostic (IVD) and rapid urbanization would drive the growth of the market. However the market ..

The US biosimilar market is forecasted to reach US$36.16 billion in 2026, experiencing growth at a CAGR of 40.16% during the period spanning from 2022 to 2026. Growth in the US biosimilar market is supported by factors such as rising prevalence of cancer, growing geriatric population and favorable environment. However, the market growth is expected to be restrained by complexities in manufactur ..

China online healthcare market is forecasted to reach US$311.48 billion in 2026, experiencing growth at a CAGR of 36.89% during the period spanning from 2022 to 2026. Growth in China online healthcare market is supported by factors such as aging population, rising health expenditure, support from Chinese government, technical innovations and rising internet penetration. However, the market grow ..

The China biological reagent market is forecasted to reach US$6.39 billion in 2026, experiencing growth at a CAGR of 14.87% during the period spanning from 2022 to 2026. Growth in the China biological reagent market was supported by factors such as increasing research in the field of life sciences, technological innovations, rising number of genome projects, rising incidence of genetic disorder ..

The global RNAi therapeutics market is expected to record a value of US$1.15 billion in 2026, progressing at a CAGR of 10.19%, over the period 2022-2026. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and progress in collaborations and associate ..

The global hemophilia market is anticipated to reach US$15.86 billion in 2026, growing at a CAGR of 5.82% during the period spanning 2022-2026. The growth in the market has been driven by factors like increasing healthcare expenditure, surging identified hemophilia patient volume, increased focus on prophylactic treatment, rise in male population and favorable government initiatives. The market ..

The global surgical robot market is forecasted to reach US$31.58 billion in 2026, experiencing growth at a CAGR of 21.19% during the period spanning from 2022 to 2026. Growth in the global surgical robot market was supported by factors such as aging population, rise in disposable income, accelerating global spending on health, advantages of robotic-assisted surgery, rapid increase in chronic di ..